SEC
Whistleblower
Attorneys

September 22, 2017

Aegerion Pharmaceuticals, Inc.

Financial Fraud

SANCTION AMOUNT: $4100000

Defendants: Aegerion Pharmaceuticals, Inc.

Sanction was a penalty that Defendant, a biopharmaceutical company, agreed to pay to settle fraud charges. Defendant allegedly exaggerated the number of new patients actually filling prescriptions for an expensive drug that was its sole source of revenue.

Thank you for submitting some email to us.